INNOVATE Phase 2 trial

March 29, 2019

Phase 3 Trial Launched to Test TTFields-Taxol Combo on Platinum-resistant Ovarian Cancer

News

Novocure has initiated a Phase 3 trial investigating its Tumor Treating Fields (TTFields) — a method that uses electric fields to disrupt cell division — in combination with Taxol (paclitaxel) ... Read more

August 3, 2018

Adding TTFields to Taxol May Help Recurrent Ovarian Cancer Patients, Study Shows

News

Adding Tumor Treating Fields (TTFields) — a therapy that uses electric fields to induce cell death — to weekly Taxol (paclitaxel) more than doubles the time to disease worsening or death in ovarian cancer patients ... Read more

April 10, 2017

TTFields, Taxol Combo Shows Promise in Recurrent Ovarian Cancer Patients

News

Patients with recurrent ovarian cancer may greatly benefit from the addition of Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, to Taxol (paclitaxel), according to ... Read more